2025 third_quarter Filing
Q3Lobbying Activities (4)
Medicare/Medicaid
View allMonitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Issues related to access to home infusion, including H.R. 993, Joe Fiandra Access to Home infusion Act of 2025.
H.R. 946/S.1862, ORPHAN Cures Act.
H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to drug pricing and pharmacy benefit management reforms. Issues related to Most Favored Nation drug pricing.
Health Issues
View allIssues related to medication step therapy.
S.864, HELP Copays Act, as it relates to out-of-pocket costs for prescription drugs. Issues related to pharmacy benefit management reforms.
Trade (domestic/foreign)
View allIssues related to tariffs.
Taxation/Internal Revenue Code
View allIssues related to the Orphan Drug Tax Credit.
H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes.